Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

Detalles Bibliográficos
Autores principales: Alexander, J, Gurwith, M, Mendy, J, Vang, L, Manayani, D, Avanzini, J, Guenther, B, Farness, P, Haynes, BF, Liao, H, Montefiori, DC, LaBranche, CC, Mayall, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441948/
http://dx.doi.org/10.1186/1742-4690-9-S2-P35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441948/
http://dx.doi.org/10.1186/1742-4690-9-S2-P35

Ejemplares similares